[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100193029":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":10,"locations":16,"responsibleParty":40,"collaborators":10,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":10,"eligibilityCriteria":50,"healthyVolunteers":46,"sex":51,"minAge":52,"maxAge":10,"enrollmentInfo":53,"targetDuration":56,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":18,"whyStopped":10,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Asan Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Drug eluting stent",null,"Patients who receiving drug eluting stents",[13],{"name":14,"affiliation":5,"role":15},"Seung-Jung Park, MD, PhD","PRINCIPAL_INVESTIGATOR",[17],{"facility":5,"status":18,"city":19,"state":10,"zip":10,"country":20,"countryCode":10,"cosmosGeoPoint":21,"geoPoint":26,"contacts":27},"RECRUITING","Seoul","South Korea",{"type":22,"coordinates":23},"Point",[24,25],126.9784,37.566,{"lat":25,"lon":24},[28,33,37,38],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},"Seung-Jung Park, MD,PhD","CONTACT","82-2-3010-4812","sjpark@amc.seoul.kr",{"name":34,"role":30,"phone":35,"phoneExt":10,"email":36},"Jung-Min Ahn, MD","82-2-3010-5904","drjmahn@gmail.com",{"name":29,"role":15,"phone":10,"phoneExt":10,"email":10},{"name":34,"role":39,"phone":10,"phoneExt":10,"email":10},"SUB_INVESTIGATOR",{"type":41,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Seung-Jung Park","MD,PhD, Chairman,Heart Institute, Asan Medical Center,University of Ulsan,College of Medicine","100193029","prospective-evaluation-of-drug-eluting-stents-in-routine-clinical-practice-asan-pci-registry-100193029",false,"NCT01788592","Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)","Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice","Inclusion Criteria:\n\n* coronary disease amenable to percutaneous coronary intervention (PCI)\n* no clinical and lesion limitations\n\nExclusion Criteria:\n\n* patients with a mixture of several drug eluting stents\n* terminal illness with life expectancy less than 1 year\n* patients with cardiogenic shock","ALL","18 Years",{"count":54,"type":55},50000,"ESTIMATED","1 Year","OBSERVATIONAL","The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the \"real world\" daily practice.",[60],"Coronary Artery Disease",[62,63],"coronary artery disease","drug eluting stent","2025-12-28",{"date":66,"type":67},"2026-01-02","ACTUAL",{"date":69,"type":67},"2003-01",{"date":71,"type":55},"2030-10",{"name":42,"class":6},1]